Myocardial mitochondrial proliferation and arrhythmias in a cyclist: The role of erythropoietin

Vincenzo Palmieri, Salvatore Francesco Gervasi, Paolo Zeppilli, Antonio Dello Russo, Carla Giordano, Giulia D’Amati

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Ventricular arrhythmias (VAs) in competitive athletes are a challenging problem. They may be linked to structural or functional cardiomyopathies, but the role of banned drugs utilization must always be considered. We report the case of a young asymptomatic professional cyclist with frequent and repetitive VAs, an apparently normal heart at imaging and history of erythropoietin (EPO) use. At the electroanatomical mapping during the electrophysiological study, a low-voltage area in the right ventricular outflow tract was documented. At biopsy, we unexpectedly found mitochondrial proliferation into myocardiocytes. As mitochondrial myopathies/cardiomyopathies were ruled out, we considered the possibility of a link between EPO assumption and this mitochondrial proliferation. In this case, moreover, the artificial and inappropriate stimulus for mitochondrial proliferation induced by EPO has the potential to explain the new occurrence of VAs.
Titolo tradotto del contributo[Autom. eng. transl.] Myocardial mitochondrial proliferation and arrhythmias in a cyclist: The role of erythropoietin
Lingua originaleItalian
pagine (da-a)453-459
Numero di pagine7
RivistaMedicina dello Sport
Volume72
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Athletes
  • Doping in sports
  • Heart
  • Sudden death

Fingerprint Entra nei temi di ricerca di 'Myocardial mitochondrial proliferation and arrhythmias in a cyclist: The role of erythropoietin'. Insieme formano una fingerprint unica.

Cita questo